Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy

被引:49
|
作者
Oberhuber, Christina [2 ]
Bulley, Sean M. [3 ]
Ballmer-Weber, Barbara K. [4 ]
Bublin, Merima [1 ]
Gaier, Sonja [1 ]
DeWitt, Asa Marknell [5 ]
Briza, Peter [6 ]
Hofstetter, Gerlinde [1 ]
Lidholm, Jonas [5 ]
Vieths, Stefan [7 ]
Hoffmann-Sommergruber, Karin [1 ]
机构
[1] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria
[2] Biomay AG, Vienna, Austria
[3] Hort & Food Res Inst New Zealand Ltd, Auckland, New Zealand
[4] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland
[5] Phadia AB, Uppsala, Sweden
[6] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria
[7] Paul Ehrlich Inst, D-6070 Langen, Germany
关键词
Bet v 1; Food allergy; Kiwifruit; Pollen allergy; Recombinant allergen;
D O I
10.1002/mnfr.200800146
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Allergy to kiwifruit appears to have become more common in Europe and elsewhere during the past several years. Seven allergens have been identified from kiwifruit so far, with actinidin, kiwellin and the thaumatin-like protein as the most relevant ones. In contrast to other fruits, no Bet v 1 homologues were characterized from kiwifruit so far. We cloned, purified, and characterized recombinant Bet v 1-homologous allergens from green (Actinidia deliciosa, Act d 8) and gold (Actinidia chinensis, Act c 8) kiwifruit, and confirmed the presence of its natural counterpart by inhibition assays. Well-characterized recombinant Act d 8 and Act c 8 were recognized by birch pollen/kiwifruit (confirmed by double-blind placebo-controlled food challenge) allergic patients in IgE immunoblots and ELISA experiments. The present data point out that Bet v 1 homologues are allergens in kiwifruit and of relevance for patients sensitized to tree pollen and kiwifruit, and might have been neglected so far due to low abundance in the conventional extracts used for diagnosis.
引用
收藏
页码:S230 / S240
页数:11
相关论文
共 50 条
  • [31] Pru du 1, the Bet v 1-homologue from almond, is a major allergen in patients with birch pollen associated almond allergy
    Kabasser, Stefan
    Crvenjak, Nadja
    Schmalz, Stefanie
    Kalic, Tanja
    Hafner, Christine
    Dubiela, Pawel
    Kucharczyk, Aleksandra
    Bazan-Socha, Stanislawa
    Lukaszyk, Mateusz
    Breiteneder, Heimo
    Radauer, Christian
    Bublin, Merima
    CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (08)
  • [32] Induction of IgE antibodies' in mice and rhesus monkeys with recombinant birch pollen allergens: Different allergenicity of Bet v 1 and Bet v 2
    Vrtala, S
    Mayer, P
    Ferreira, F
    Susani, M
    Sehon, AH
    Kraft, D
    Valenta, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (05) : 913 - 921
  • [33] Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients' sera
    Guhsl, Eva Elisabeth
    Hofstetter, Gerlinde
    Hemmer, Wolfgang
    Ebner, Christof
    Vieths, Stefan
    Vogel, Lothar
    Breiteneder, Heimo
    Radauer, Christian
    MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (03) : 625 - 634
  • [34] Prophylactic approach for tolerance induction in a murine model of the major birch pollen allergy, Bet v 1
    Campana, R.
    Akinfenwa, O.
    Huang, H.
    Linhart, B.
    Focke-Tejkl, M.
    Vrtala, S.
    Poroshiva, A.
    Nikonova, A.
    Khaitov, M.
    Campion, N. J.
    Eckl-Dorna, J.
    Niederberger-Leppin, V.
    Kratzer, B.
    Tauber, P. A.
    Pickl, W. F.
    Kundi, M.
    Valenta, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 197 - 198
  • [35] Effects of birch pollen AIT on antibody profiles of Bet v 1 and cross-reactive food allergens
    Huber, S.
    Hofer, H.
    Lang, R.
    Hawranek, T.
    Rauber, M.
    Asam, C.
    Ferreira, F.
    Wallner, M.
    ALLERGY, 2016, 71 : 452 - 452
  • [36] Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles
    Rossi, RE
    Monasterolo, G
    Monasterolo, S
    ALLERGY, 2003, 58 (09) : 929 - 932
  • [37] Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses asthmatic features in a murine model of birch pollen allergy
    Siebeneicher, S.
    Reuter, S.
    Wangorsch, A.
    Krause, M.
    Foetisch, K.
    Heinz, A.
    Naito, S.
    Reuter, A.
    Taube, C.
    Vieths, S.
    Scheurer, S.
    Toda, M.
    ALLERGY, 2016, 71 : 230 - 230
  • [38] CHARACTERIZATION OF BET-V-1, THE MAJOR ANTIGEN OF BIRCH POLLEN BY MEANS OF TWO-DIMENSIONAL ELECTROPHORESIS COMBINED WITH IMMUNOBLOTTING
    RUMPOLD, H
    JAROLIM, E
    ENDLER, AT
    ROHAC, M
    SCHREINER, O
    KRAFT, D
    ELECTROPHORESIS, 1988, 9 (10) : 635 - 635
  • [39] Structural characterisation of a recombinant Bet v 1 allergen established as a safe and efficacious treatment for birch pollen allergy
    Nony, E.
    Le Mignon, M.
    Lemoine, P.
    Jain, K.
    Didierlaurent, A.
    Batard, T.
    Moingeon, P.
    ALLERGY, 2014, 69 : 561 - 561
  • [40] Monitoring the induction of blocking antibodies towards Bet v 1 and associated food allergens during birch pollen AIT
    Huber, S.
    Hofer, H.
    Lang, R.
    Hawranek, T.
    Rauber, M.
    Ferreira, F.
    Wallner, M.
    ALLERGY, 2015, 70 : 461 - 462